(Q36961016)

17 August 2017

1 reference

title

Modulation of NK cell activity by CpG oligodeoxynucleotides (English)

1 reference

17 August 2017

Zuhair K Ballas

1

1 reference

17 August 2017

publication date

1 January 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

39

1 reference

17 August 2017

issue

1-3

1 reference

17 August 2017

page(s)

15-21

1 reference

https://scigraph.springernature.com/pub.10.1007/s12026-007-0066-3

17 August 2017

exact match

0 references

cites work

Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs.

1 reference

https://api.crossref.org/works/10.1007%2FS12026-007-0066-3

Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-007-0066-3

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-007-0066-3

The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-007-0066-3

Lymphokine-activated killer (LAK) cells. IV. Characterization of murine LAK effector subpopulations.

21 January 2018

1 reference

12 December 2020

Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses

1 reference

12 December 2020

CpG motifs: the active ingredient in bacterial extracts?

1 reference

12 December 2020

Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.

1 reference

12 December 2020

TLR9 in health and disease

1 reference

12 December 2020

Lymphokine-activated killer (LAK) cells. II. Delineation of distinct murine LAK-precursor subpopulations.

1 reference

12 December 2020

CpG motifs to modulate innate and adaptive immune responses

1 reference

12 December 2020

Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA

1 reference

12 December 2020

Lymphokine-activated killer cells. VII. IL-4 induces an NK1.1+CD8 alpha+beta- TCR-alpha beta B220+ lymphokine-activated killer subset.

1 reference

12 December 2020

Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma

1 reference

12 December 2020

1 reference

12 December 2020

Close encounters of different kinds: dendritic cells and NK cells take centre stage

1 reference

12 December 2020

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells

1 reference

12 December 2020

Structural characterization of the inhibitory DNA motif for the type A (D)-CpG-induced cytokine secretion and NK-cell lytic activity in mouse spleen cells

1 reference

12 December 2020

CpG DNA induces cyclooxygenase-2 expression and prostaglandin production.

1 reference

12 December 2020

Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes.

1 reference

12 December 2020

NK cell and DC interactions

1 reference

12 December 2020

Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide

1 reference

12 December 2020

10.1007/S12026-007-0066-3

Identifiers

DOI

1 reference

17 August 2017

1 reference